Management of Steroid-Induced Diabetes
For steroid-induced diabetes, NPH insulin administered in the morning is the preferred treatment to match the pharmacokinetics of glucocorticoids like prednisolone, which cause peak hyperglycemia 6-9 hours after morning administration. 1, 2
Understanding Steroid-Induced Hyperglycemia
- Glucocorticoids induce hyperglycemia through multiple mechanisms: impaired beta cell insulin secretion, increased insulin resistance, and enhanced hepatic gluconeogenesis 1, 2
- The hyperglycemic effect is most pronounced during the day (particularly afternoon and evening) and often normalizes overnight, even without treatment 2
- The degree of hyperglycemia directly correlates with the steroid dose - higher doses cause more significant elevations in blood glucose 1, 2
- Steroid-induced hyperglycemia occurs in 56-86% of hospitalized patients with and without pre-existing diabetes 3, 2
Monitoring Recommendations
- Blood glucose monitoring should be performed four times daily (fasting and 2 hours after each meal) 1
- Target blood glucose range should be 5-10 mmol/L (90-180 mg/dL) 1
- Peak hyperglycemic effects should be anticipated 6-9 hours after administration, making afternoon glucose monitoring particularly important 2
Treatment Algorithm
For Patients Not Previously on Diabetes Medications:
Initial Treatment:
Dose Adjustments:
For Patients Already on Diabetes Medications:
Oral Antidiabetic Agents:
Patients Already on Insulin:
Special Considerations
- For elderly patients or those with renal impairment, start with lower insulin doses (0.2-0.3 units/kg/day) 1
- Monitor for hyperosmolar hyperglycemic state, a life-threatening complication of severe steroid-induced hyperglycemia 1
- For long-acting glucocorticoids such as dexamethasone, long-acting basal insulin may be required to manage fasting blood glucose levels 3
Perioperative Management
- For patients requiring surgery while on steroids:
- Target blood glucose in the perioperative period should be 100–180 mg/dL (5.6–10.0 mmol/L) 3
- Hold oral glucose-lowering agents on the day of surgery 3
- Give half of NPH dose or 75–80% doses of long-acting insulin 3
- Monitor blood glucose at least every 2–4 h while NPO and dose with short- or rapid-acting insulin as needed 3
Common Pitfalls to Avoid
- Failing to anticipate the diurnal pattern of steroid-induced hyperglycemia, with peak effects in the afternoon and evening 1, 2
- Using only fasting glucose to monitor steroid-induced hyperglycemia (will miss the peak hyperglycemic effect) 2
- Not reducing insulin doses when steroid doses are tapered, leading to hypoglycemia 1, 2
- Relying solely on oral antidiabetic agents for high-dose steroid therapy 1